Clinical trial
NIS Xeloda in Gastric Cancer
NCT02274376 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- NIS Xeloda in Gastric Cancer
- Lead sponsor
- Hoffmann-La Roche
- Phase
- Observational
- Overall status
- Completed
- Start date
- August 31, 2008
- Completion date
- December 31, 2012
- Enrollment
- 223 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
gastric cancer